NTLA DCF Valuation - Intellia Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 12.11 USD -1.94% Market Closed

Market Cap: $1.7B

	Intellia Therapeutics Inc NASDAQ:NTLA	US
W	Workhorse Group Inc F:1WO	US
	Minerva Surgical Inc OTC:UTRS	US
	Tower Bersama Infrastructure Tbk PT IDX:TBIG	ID
	Cerence Inc NASDAQ:CRNC	US
	Feng Tay Enterprises Co Ltd TWSE:9910	TW
	Multistrada Arah Sarana Tbk PT IDX:MASA	ID
	Central Omega Resources Tbk PT IDX:DKFT	ID
T	Touchstone Exploration Inc LSE:TXP	CA
	Soitec SA PAR:SOI	FR
	General Motors Co NYSE:GM	US
	Texas Pacific Land Corp NYSE:TPL	US
	Genetec Corp TSE:4492	JP
	Griffon Corp NYSE:GFF	US
	Deutsche Telekom AG MIL:DTE	DE
S	Selan Exploration Technology Ltd NSE:SELAN	IN

NTLA's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.